Topic: Retatrutide for Obesity — A Phase 2 Trial

Objective(s): glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects, safety, and efficacy for the treatment of obesity are not known.

Speaker: Dr. Brittany Maffett

Session date: 
01/09/2024 - 7:00am to 8:00am EST
Location: 
iTOR Bright Conference Room
701 Grove Road
Greenville, SC 29605
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    The University of South Carolina School of Medicine Greenville designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The University of South Carolina School of Medicine Greenville is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance

Please login or register to take this course.